SCHEMBL31444288

SCHEMBL31444288

COC(=O)c1ccc(N2CC(O)CC2c2ccccc2Cl)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.43
ALDH1A1 P00352 6/20 0.38
KDM4E B2RXH2 4/20 0.38
GLA P06280 4/20 0.38
GAA P10253 4/20 0.38
HPGD P15428 2/20 0.38
CASP1 P29466 2/20 0.38
CASP7 P55210 2/20 0.38
HSD17B10 Q99714 2/20 0.38
TSHR P16473 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
MAPK1 P28482 1/20 0.38
ROCK2 O75116 3/20 0.38
HSP90AA1 P07900 2/20 0.36
HSP90AB1 P08238 2/20 0.36
ATM Q13315 1/20 0.35
KMT2A Q03164 2/20 0.34
MAPT P10636 1/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31444516 0.89 NR1H4 (0.43) NR1H4ALDH1A1KDM4EGLAGAA
SCHEMBL31444342 0.87 RORC (0.43) NR1H4KDM4EL3MBTL1ROCK2HSP90AA1
SCHEMBL31444351 0.86 NR1H4 (0.41) NR1H4ALDH1A1KDM4EGLAGAA
SCHEMBL31444261 0.83 ALDH1A1 (0.43) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL31444401 0.80 NR1H4 (0.39) NR1H4ALDH1A1KDM4EGLAGAA
SCHEMBL31444409 0.80 NR1H4 (0.41) NR1H4ALDH1A1KDM4EGLAGAA
SCHEMBL31444366 0.80 RORC (0.40) NR1H4HSP90AA1HSP90AB1FFAR2USP30
SCHEMBL31444503 0.79 NR1H4 (0.38) NR1H4ALDH1A1KDM4EGLAGAA
SCHEMBL31444520 0.76 RORC (0.43) NR1H4ALDH1A1KDM4EGLAGAA
SCHEMBL30525307 0.72 USP30 (0.44) ALDH1A1KDM4EHPGDHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072451-A1 RAS-PI3K INHIBITORS FOR THE TREATMENT OF CANCER AND IMMUNOLOGICAL DISEASES VIVIDION THERAPEUTICS, INC. (US) 2025-04-03 WO disclosed